Zedong Dong

FDA investigator

Appears on 3 documents from 2017 to 2020, most often at sites in China. Most often cites design controls (21 CFR 820.30).

3
Documents on file
8.7
Observations per 483
2017
First seen
2020
Most recent

What they cite most

From 26 observations

Activity by year

2017: 1, 2019: 1, 2020: 1

Where

China 1 · India 1 · Missouri 1

Is Zedong Dong coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

3 documents, newest first
FirmOpen
483 Solara Active Pharma Sciences LimitedMar 7, 2020 · Cuddalore, India
483 Zhejiang Huahai Pharmaceutical Co., Ltd.May 31, 2019 · Linhai, China
483 Meridian Medical Technologies, Inc. a Pfizer CompanyMar 24, 2017 · Brentwood, Missouri

About this profile

What does Zedong Dong inspect?

Zedong Dong appears on 3 documents on file covering 3 sites, most often in China.

What do they cite most often?

21 CFR 820.30 (design controls), followed by 21 CFR 211.160 and 21 CFR 211.192.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Zedong Dong is dated Mar 7, 2020.

FDA Investigator Zedong Dong: 483s & Inspections · FDA Intel